Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors
Main Authors: | Jiang Li, Min Zhao, Lei Chen, Qin Zhang, Gang Wang, Junnian Zheng, Lin Fang, Lunxiu Qin, Changqing Su, Yinghan Su, Weidan Ji, Lin Ang, Yuan Sen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-05-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/10/5/e004691.full |
Similar Items
-
Chimeric Oncolytic Adenovirus Armed Chemokine Rantes for Treatment of Breast Cancer
by: Lin Ang, et al.
Published: (2022-07-01) -
Rodents Versus Pig Model for Assessing the Performance of Serotype Chimeric Ad5/3 Oncolytic Adenoviruses
by: Lisa Koodie, et al.
Published: (2019-02-01) -
Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses
by: Gabriela Green-Tripp, et al.
Published: (2022-06-01) -
Preclinical safety studies of enadenotucirev, a chimeric group B human-specific oncolytic adenovirus
by: Illingworth, S, et al.
Published: (2017) -
Oncolytic Adenoviruses for Cancer Therapy
by: Lorella Tripodi, et al.
Published: (2021-03-01)